Urinary N-telopeptide levels discriminate normal, osteopenic, and osteoporotic bone mineral density

Archives of Internal Medicine

Volumn 157, Issue 11, 1997, Pages 1241-1245

  Schneider, Diane L ^a   Barrett Connor, Elizabeth L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PREDICTION; PRIORITY JOURNAL; URINE LEVEL;

EID: 0030991646     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.11.1241     Document Type: Article

References (17)

1. Cummings SR, Black DM, Nevitt MC, et al. Bone density at various sites for prediction of hip fractures. Lancet. 1993;341:72-75.
2. Hanson DA, Weis MA, Bollen AM, Maslan SL, Singer FR, Eyre DR. A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res. 1992;7:1251-1258.
3. Rosen HN, Dresner-Pollak R, Moses AC, et al. Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover. Calcif Tissue Int. 1994;54:26-29.
4. Gertz BJ, Shao P, Hanson DA, et al. Monitoring bone resorption in early post-menopausal women by an immunoassay for cross-linked collagen peptides in urine. J Bone Miner Res. 1994;9:135-142.
5. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985;122:51-65.
6. WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Tech Rep Ser. 1994;843:1-129.
7. Looker AC, Johnston CC Jr, Wahner HW, et al. Prevalence of low femoral bone density in older U.S. women from NHANES III. J Bone Miner Res. 1995;10: 796-802.
8. Fleiss JL. Statistical Methods for Rates and Proportions. New York, NY: John Wiley & Sons Inc; 1981:13-15.
9. Thomsen K, Gotfredsen A, Christiansen C. Is postmenopausal bone loss an age-related phenomenon? Calcif Tissue Int. 1986;36:123-127.
10. Gallagher JC, Goldar D, Moy A. Total bone calcium in normal women: effect of age and menopause status. J Bone Miner Res. 1987;2:491-496.
11. Eastell R, Delmas PD, Hodgson SF, et al. Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics and biochemical markers. J Clin Endocrinol Metab. 1988;67:741-748.
12. aalendronate treatment. J Clin Endocrinol Metab. 1994; 79:1693-1700.
13. Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res. 1996;11:337-349.
14. Campodarve I, Ulrich U, Bell N, et al. Urinary N-telopeptides of type I collagen monitors bone resorption and may predict change in bone mass of the spine in response to hormone replacement therapy. J Bone Miner Res. 1995;10 (suppl):S182.
15. Prestwood KM, Pilbeam CC, Burleson JA, et al. The short term effects of conjugated estrogen on bone turnover in older women. J Clin Endocrinol Metab. 1994;79:366-371.
16. Akesson K, Vergnaud P, Gineyts E, Delmas PD, Obrant K. Impairment of bone turnover in elderly women with hip fracture. Calcif Tissue Int. 1993;53:162-169.
17. Garnero P, Hausher E, Chapuy MC, et al. Can markers of bone turnover predict hip fractures in elderly women? the EPIDOS Study. J Bone Miner Res. 1995:10(suppl):S140.